Syndax Free Cash Flow from 2010 to 2024

SNDX Stock  USD 14.94  0.62  3.98%   
Syndax Pharmaceuticals Free Cash Flow yearly trend continues to be fairly stable with very little volatility. Free Cash Flow is likely to outpace its year average in 2024. Free Cash Flow is the amount of cash Syndax Pharmaceuticals generates after accounting for cash outflows to support operations and maintain its capital assets. View All Fundamentals
 
Free Cash Flow  
First Reported
2012-12-31
Previous Quarter
-71.6 M
Current Value
-62.3 M
Quarterly Volatility
25.5 M
 
Yuan Drop
 
Covid
Check Syndax Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Syndax Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.4 K, Interest Expense of 197.6 K or Selling General Administrative of 57.1 M, as well as many indicators such as Price To Sales Ratio of 6.97, Dividend Yield of 0.0198 or PTB Ratio of 2.88. Syndax financial statements analysis is a perfect complement when working with Syndax Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Syndax Pharmaceuticals Correlation against competitors.
For more information on how to buy Syndax Stock please use our How to Invest in Syndax Pharmaceuticals guide.

Latest Syndax Pharmaceuticals' Free Cash Flow Growth Pattern

Below is the plot of the Free Cash Flow of Syndax Pharmaceuticals over the last few years. It is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets. Syndax Pharmaceuticals' Free Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Syndax Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow10 Years Trend
Slightly volatile
   Free Cash Flow   
       Timeline  

Syndax Free Cash Flow Regression Statistics

Arithmetic Mean(49,574,997)
Geometric Mean28,930,470
Coefficient Of Variation(117.33)
Mean Deviation45,361,596
Median(35,418,000)
Standard Deviation58,168,602
Sample Variance3383.6T
Range189.6M
R-Value(0.74)
Mean Square Error1658T
R-Squared0.54
Significance0
Slope(9,602,184)
Total Sum of Squares47370.2T

Syndax Free Cash Flow History

2024-152.6 M
2023-160.6 M
2022-133.9 M
202129 M
2020-71.3 M
2019-50.6 M
2018-68.7 M

Other Fundumenentals of Syndax Pharmaceuticals

Syndax Pharmaceuticals Free Cash Flow component correlations

About Syndax Pharmaceuticals Financial Statements

Syndax Pharmaceuticals investors use historical fundamental indicators, such as Syndax Pharmaceuticals' Free Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Syndax Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Free Cash Flow-160.6 M-152.6 M
Free Cash Flow Yield(0.11)(0.11)
Free Cash Flow Per Share(2.28)(2.40)
EV To Free Cash Flow(7.64)(8.02)
Price To Free Cash Flows Ratio(9.47)(9.94)
Free Cash Flow Operating Cash Flow Ratio 1.15  1.10 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Syndax Stock Analysis

When running Syndax Pharmaceuticals' price analysis, check to measure Syndax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syndax Pharmaceuticals is operating at the current time. Most of Syndax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syndax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syndax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syndax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.